Microdosing and standard‐dosing take‐home buprenorphine from the emergency department: A feasibility study
Journal of the American College of Emergency Physicians Open2020Vol. 1(6), pp. 1712–1722
Citations Over TimeTop 10% of 2020 papers
Jessica Moe, Katherin Badke, Megan E. Pratt, Raymond Y. Cho, Pouya Azar, Heather Flemming, Karen Sutherland, Barbara Harvey, Lara Gurney, Julie Lockington, Penny Brasher, Sam Gill, Emma Garrod, Misty Bath, Andy Kestler
Abstract
ED-initiated take-home standard-dosing and microdosing buprenorphine/naloxone programs are feasible, and a randomized controlled trial would be acceptable to our target population.
Related Papers
- → The Next Stage of Buprenorphine Care for Opioid Use Disorder(2018)133 cited
- → Prior Buprenorphine Experience Is Associated With Office-Based Buprenorphine Treatment Outcomes(2013)39 cited
- Implantable Buprenorphine (Probuphine) for Maintenance Treatment of Opioid Use Disorder.(2018)
- → Analgesic efficacy of orally administered buprenorphine in rats: methodologic considerations.(2004)8 cited